50 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87.
Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday.
Mid-Day Market Update: Stocks Extend Losses; Dow Tumbles Over 400 Points
U.S. stocks extended its earlier losses midway through trading on Tuesday, amid rising tensions between Russia and Ukraine. Russian President Vladimir Putin said he would recognize the independence of two Russian-led breakaway regions of Ukraine and ordered Russian troops to go into eastern Ukraine.
B of A Securities Maintains Buy on Homology Medicines, Lowers Price Target to $9
B of A Securities analyst Jason Zemansky maintains Homology Medicines (NASDAQ:FIXX) with a Buy and lowers the price target from $25 to $9.
Mid-Morning Market Update: U.S. Markets Mixed Amid Russia-Ukraine Woes
U.S. stocks traded mixed this morning, amid rising tensions between Russia and Ukraine. Russian President Vladimir Putin said he would recognize the independence of two Russian-led breakaway regions of Ukraine and ordered Russian troops to go into eastern Ukraine.
Chardan Capital Maintains Buy on Homology Medicines, Lowers Price Target to $15
Chardan Capital analyst Geulah Livshits maintains Homology Medicines (NASDAQ:FIXX) with a Buy and lowers the price target from $25 to $15.
BTIG Maintains Buy on Homology Medicines, Lowers Price Target to $29
BTIG analyst Robert Hazlett maintains Homology Medicines (NASDAQ:FIXX) with a Buy and lowers the price target from $35 to $29.
Homology Medicines Stock Plunges After FDA Clinical Hold On Gene Therapy Trial
The FDA has placed a clinical hold on Homology Medicines Inc's (NASDAQ:
RBC Capital Downgrades Homology Medicines to Sector Perform, Lowers Price Target to $4
RBC Capital analyst Luca Issi downgrades Homology Medicines (NASDAQ:FIXX) from Outperform to Sector Perform and lowers the price target from $30 to $4.
Homology Medicines Reports FDA Notified Co. Its pheNIX Gene Therapy Trial In Adults With Phenylketonuria Placed On Clinical Hold Due To ‘ need to modify risk mitigation measures in the study in response to observations of elevated liver function tests’
Homology Medicines, Inc. (NASDAQ:FIXX), a genetic medicines company, announced today that the U.S. Food and Drug Administration (FDA) has notified the company that its pheNIX gene therapy trial of HMI-102 in adults with